| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $923K | -30.0% | +11.1% |
| SG&A Expense | $1.0M | -10.8% | +5.6% |
| Operating Income | -$1.9M | +21.1% | -8.1% |
| Income Tax | $0 | — | — |
| Net Income | -$1.9M | +22.0% | +14.9% |
| EPS (Basic) | -$1.77 | +74.8% | -110.7% |
| EPS (Diluted) | -$1.77 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.7M | +145.6% | +94.3% |
| Current Assets | $12.8M | +139.4% | +92.7% |
| Total Assets | $12.9M | +138.3% | +90.7% |
| Current Liabilities | $1.9M | +18.2% | -54.4% |
| Total Liabilities | $1.9M | +18.2% | -54.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | — | — |
| Capital Expenditures | $37K | — | — |
| Investing Cash Flow | -$37K | — | — |
| Financing Cash Flow | $12.5M | — | — |
| Free Cash Flow | -$6.3M | — | — |
| -110.7% |
| $11.0M |
| +187.6% |
| +311.5% |